GE's SIGNA 7.0T MRI Receives FDA Clearance

By News Release

GE Healthcare's SIGNA 7.0T is now 510(k) cleared. With a powerful 7.0 tesla magnet at its core, SIGNA 7.0T combines a broad range of advanced technology, imaging methods, and years of GE Healthcare experience into a new imaging tool. The completely new SIGNA 7.0T features UltraG gradient technology, GE’s most powerful whole-body gradient coil, to meet the demands of ultra-high field imaging speed and resolution, advanced diffusion, and functional brain imaging. This new scanner can be used for both research and clinical purposes to support a broad range of investigations across neurologic and musculoskeletal diseases. 

 “We were immediately impressed with the quality and stability of the SIGNA 7.0T system,” said Michela Tosetti, PhD, Laboratory Director, IRCCS Stella Maris and Imago7 Research Foundations and professor, University of Pisa, who scanned on SIGNA 7.0T at GE Healthcare MR headquarters earlier this year. “We are keen to upgrade our system to this new configuration continuing our relationship with GE to realize the promise of this technology to meet our imaging goals.” 

With a powerful 7.0 tesla magnet at its core, SIGNA 7.0T combines a broad range of advanced technology, imaging methods, and years of GE Healthcare experience into a new imaging tool. The completely new SIGNA 7.0T features UltraG gradient technology, GE’s most powerful whole-body gradient coil, to meet the demands of ultra-high field imaging speed and resolution, advanced diffusion, and functional brain imaging.

This system also features GE’s latest SIGNAWorks software platform with state-of-the-art applications such as deep learning-based tools like AIR x brain for automated slice positioning and Silent MR imaging, enabling seamless protocol translation between GE MR systems. In addition, SIGNA 7.0T is equipped with Precision RF transmit and receive architecture to enable improved image quality and enable development in parallel transmit. This system also provides a unique platform for advanced knee and cartilage imaging, allowing for ultra-high-resolution anatomical visualization as well as research capabilities to measure quantitative changes in anatomy due to disease.

“We are thrilled to add SIGNA 7.0T to our portfolio,” said Jie Xue, president and CEO of GE Healthcare MR. “This new scanner is a critical tool in research for neurological disorders like Alzheimer’s disease and mild traumatic brain injury. Now clinicians will have access to the power of ultra-high field imaging combined with the ultra-high-performance gradients to translate research advances into new clinical diagnostic tools and potential treatment options.”

Back To Top

GE's SIGNA 7.0T MRI Receives FDA Clearance.  Appl Radiol. 

By News Release| November 11, 2020

About the Author

News Release

News Release

Copyright © Anderson Publishing 2020